TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
U.S. HPV vaccination guidance is under active revision as federal officials, the AAP, and an advisory committee workgroup all explore whether one dose could replace two. For now, experts still advise two doses for preteens, with about 63% of teens currently completing the series.
U.S. recommendations for the HPV vaccine are in flux, as federal officials, the American Academy of Pediatrics, and a CDC advisory workgroup have all separately explored whether one dose could replace the current two-dose schedule for adolescents. Health Secretary Robert F. Kennedy Jr. ordered a reduction to one dose in January as part of broader cuts to the childhood vaccination schedule, but a federal judge blocked that change — leaving the two-dose recommendation in place while expert deliberations continue.
According to reporting by MedPage Today, the idea of a single-dose HPV vaccine regimen predates the secretary’s order. A study in Costa Rica that tracked more than 20,000 girls over five years, published late last year, found a single shot provided about 97% protection against cervical cancer — similar to two doses. A year earlier, in 2024, research developments had already prompted a CDC advisory committee to form a workgroup to explore revising the recommendation; that work was interrupted when Kennedy dismissed the committee’s members.
The American Academy of Pediatrics, which makes its own vaccination recommendations and is among the medical groups that sued Kennedy, has also been considering a guidance change. Dr. James Campbell, chair of the AAP’s committee on infectious diseases, said the organization is exploring questions such as whether one dose is sufficient for at least some people and at what age vaccination should begin.
Despite the evolving discussion, experts currently advise that kids receive two doses. Current U.S. recommendations prioritize vaccination at ages 11 and 12, though the vaccines — Merck’s Gardasil, approved in 2006, and GSK’s Cervarix, approved in 2009 — are approved for males and females from age 9 through adulthood. The shots work best when given before a person becomes sexually active.
Why the Dose Question Matters
The outcome of this debate affects millions of families: HPV vaccination is one of the most effective tools for preventing a range of cancers, and any change to the recommended schedule would reshape routine pediatric care across the country. A move to a single dose could make vaccination simpler and cheaper, potentially improving completion rates — which have stalled at about 63% of teens receiving both doses, partly because many states do not require the vaccine for school attendance and completing a multi-dose series requires return visits.
At the same time, the manner in which the guidance changes matters as much as whether it changes. A recommendation revised through the traditional expert review process would carry scientific credibility, while a schedule altered by unilateral political action — as attempted in January before the courts intervened — has raised concern among medical groups about public trust. Conflicting signals between federal officials, the CDC advisory process, and the AAP could leave parents and clinicians uncertain about the right course, making clear, evidence-based communication especially important while the question remains open.
How the Recommendations Got Here
When the first HPV vaccine debuted in 2006, it was recommended only for girls as a three-shot series over six months. Boys were added to the recommendations in 2011. Ten years ago, the government reduced the recommended number of doses from three to two after studies showed that amount offered sufficient protection, and research suggested the two doses worked best when spaced 6 to 12 months apart — allowing them to be given at annual checkups.
Recent evidence on vaccine performance has continued to be favorable. The University of Minnesota’s Vaccine Integrity Project published a research review this year finding HPV vaccines lowered the risk of genital-area cancers in women. A study published in April in JAMA Oncology found vaccinated males are nearly 50% less likely to develop cancers of the head and neck, esophagus, anus, or penis.
The political environment has complicated the picture. Before becoming health secretary, Kennedy worked as an attorney and consultant in lawsuits against Merck over Gardasil and falsely claimed the vaccine increases cervical cancer risk, according to the MedPage Today report.
“This would be a significant shift in terms of what has been communicated for many years about the best way to protect adolescents against HPV.”
— Jason Schwartz, PhD, Yale University vaccine policy researcher
What Is Still Unsettled
It is not yet clear when, or whether, U.S. recommendations will formally change to one dose. The secretary’s January order was blocked by a federal judge, and the CDC advisory committee’s workgroup exploration was interrupted when its members were dismissed. The AAP says it is still exploring questions including whether one dose is sufficient for at least some people and the appropriate starting age. Whether a single dose provides protection as durable as two doses over a lifetime also remains an open research question.
Watchpoints for Families and Clinicians
Families should follow the current expert advice — two doses for adolescents, ideally starting at ages 11–12 — unless and until official guidance changes. The AAP’s ongoing review could produce a revised recommendation, and litigation over the federal vaccination schedule changes continues in the courts. Any questions about an individual child’s vaccination schedule should be discussed with a pediatrician or other qualified healthcare provider.
Key Questions
Should my child get one HPV shot or two right now?
Experts currently advise two doses. While a single-dose schedule is under discussion by federal officials and medical organizations, no finalized U.S. recommendation supporting one dose for routine use is in effect after a court blocked the health secretary’s order. Consult your pediatrician about your child’s specific situation.
What did the Costa Rica study find?
The study tracked more than 20,000 girls over five years and found a single HPV shot provided about 97% protection against cervical cancer, similar to the protection from two doses, according to the MedPage Today report.
At what age should HPV vaccination start?
Vaccines are approved for ages 9 through adulthood, but recommendations prioritize 11- and 12-year-olds because the shots work best before a person becomes sexually active.
Why are HPV vaccination rates lower than for other adolescent vaccines?
According to a recent CDC report, HPV vaccination rates are lower partly because most states do not require the vaccine for school attendance. About 63% of teenagers have received both doses, a rate that has been flat for four years.
How effective is the HPV vaccine according to research?
Studies in multiple countries have shown decreases in HPV infections, genital warts, and precancerous cervical lesions. A Vaccine Integrity Project review found lowered risk of genital-area cancers in women, and an April JAMA Oncology study found vaccinated males were nearly 50% less likely to develop certain head, neck, esophageal, anal, and penile cancers.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
